The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Korableva N.P.

St. Petersburg State Pediatric Medical University

Romanenkov N.S.

St. Petersburg State Pediatric Medical University

Kremlev D.I.

St. Petersburg State Pediatric Medical University

Kosulin A.V.

St. Petersburg State Pediatric Medical University

Nekrasov A.A.

St. Petersburg State Pediatric Medical University

Kovalenko A.P.

St. Petersburg State Pediatric Medical University

Miroshnichenko M.S.

St. Petersburg State Pediatric Medical University

Arbekov P.V.

St. Petersburg State Pediatric Medical University

Prevention of pathological skin scars (experimental study)

Authors:

Korableva N.P., Romanenkov N.S., Kremlev D.I., Kosulin A.V., Nekrasov A.A., Kovalenko A.P., Miroshnichenko M.S., Arbekov P.V.

More about the authors

Journal: Plastic Surgery and Aesthetic Medicine. 2025;(1): 32‑38

DOI: 10.17116/plast.hirurgia202501132

Read: 1599 times

Download PDF (RU)
Download PDF
Contact the author
Table of contents

PREVENTION OF PATHOLOGICAL SKIN SCARS (EXPERIMENTAL STUDY)
PREVENTION OF PATHOLOGICAL SKIN SCARS (EXPERIMENTAL STUDY)

To cite this article:

Korableva NP, Romanenkov NS, Kremlev DI, et al. . Prevention of pathological skin scars (experimental study). Plastic Surgery and Aesthetic Medicine. 2025;(1):32‑38. (In Russ., In Engl.)
https://doi.org/10.17116/plast.hirurgia202501132

Подписка 2026 Пластическая хирургия и эстетическая медицина (Plastic Surgery and Aesthetic Medicine)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Botu­linum toxin type A inje­ction in the middle and lower thirds of the face and neck area for aesthetic purposes. Plastic Surgery and Aesthetic Medi­cine. 2025;(3):108-117
Evaluation of the effi­cacy and safety of botu­linum toxin type A inje­ctions for the prevention of aspi­ration complications in patients with neurogenic dysphagia and posterior sialorrhea of various etiologies. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):126-133
Effi­cacy of Abobotulinumtoxin A (Dysport) in stump preparation for prosthetic fitting in patients with combat-related limb ampu­tations. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(2):77-82
Abstract:

OBJECTIVE

To estimate the efficacy of botulinum toxin type A in prevention of hypertrophic and keloid skin scars.

MATERIAL AND METHODS

Experimental animals were 3 rabbits Soviet Chinchilla breed. Five ellipsoid wounds were inflicted and then sutured on the outer surface of each ear. The right ear was control, and the left ear was experimental. After 7 days, 2 units of botulinum toxin type A were injected into the scars on the experimental ear. At the control points (14, 28, 42 days), scars were assessed visually. Biopsy was performed with assessment of fibroblasts and myofibroblasts.

RESULTS

Visual assessment of scars in the control group revealed hypertrophic scars in 4 out of 15 cases. In the experimental group, no hypertrophic scars were detected. In 42 days after botulinum toxin type A injection, there were fewer fibroblasts in the experimental group (p=0.01). The number of myofibroblasts in scar tissue of experimental animals in 14, 28 and 42 days after botulinum toxin type A injection was 2 times lower than in the control group (p=0.000003).

CONCLUSION

Botulinum toxin type A is effective for prevention of hypertrophic and keloid scars due to its effect on fibroblasts and myofibroblasts.

Keywords:

botulinum toxin type A
scar correction
hypertrophic scars
keloid scars
prevention of pathological scars

Authors:

Korableva N.P.

St. Petersburg State Pediatric Medical University

Romanenkov N.S.

St. Petersburg State Pediatric Medical University

Kremlev D.I.

St. Petersburg State Pediatric Medical University

Kosulin A.V.

St. Petersburg State Pediatric Medical University

Nekrasov A.A.

St. Petersburg State Pediatric Medical University

Kovalenko A.P.

St. Petersburg State Pediatric Medical University

Miroshnichenko M.S.

St. Petersburg State Pediatric Medical University

Arbekov P.V.

St. Petersburg State Pediatric Medical University

Received:

18.06.2024

Accepted:

12.07.2024

Close metadata

References:

  1. Li Y-H, Yang J, Liu J-Q, Xie S-T, Zhang Y-J, Zhang W, Zhang J-L, Zheng Z, Hu D-H. A Randomized, Placebo-Controlled, Double-Blind, Prospective Clinical Trial of Botulinum Toxin Type A in Prevention of Hypertrophic Scar Development in Median Sternotomy Wound. Aesthetic Plast Surg. 2018 Oct;42(5):1364-1369. Epub 2018 July 17. PMID: 30019241. https://doi.org/10.1007/s00266-018-1187-x
  2. Tawfik AA, Ali RA. Evaluation of botulinum toxin type A for treating post burn hypertrophic scars and keloid in children: An intra-patient randomized controlled study. J Cosmet Dermatol. 2023;22(4):1256-1260. https://doi.org/10.1111/jocd.15634
  3. Chen Z, Chen Z, Pang R, Wei Z, Zhang H, Liu W, Li G. The effect of botulinum toxin injection dose on the appearance of surgical scar. Sci Rep. 2021;11(1):13670. https://doi.org/10.1038/s41598-021-93203-x
  4. Kasyanju Carrero LM, Ma W-W, Liu H-F, Yin X-F, Zhou B-R. Botulinum toxin type A for the treatment and prevention of hypertrophic scars and keloids: Updated review. J Cosmet Dermatol. 2019;18(1):10-15. Epub 2018 Dec 12. PMID: 30548742. https://doi.org/10.1111/jocd.12828
  5. Wang Y-X, Wang Y, Zhang Q, Zhang R-D. Current Research of Botulinum Toxin Type A in Prevention and Treatment on Pathological Scars. Dermatol Surg. 2023;49(5S):S34-S40.  https://doi.org/10.1097/DSS.0000000000003770
  6. Huang Y-L, Wallace CG, Hsiao Y-C, Lee M-C, Huang J-J, Chang FC-S, Chen ZC, Hu S, Chen J-P. Botulinum Toxin to Improve Lower Blepharoplasty Scar: A Double-Blinded, Randomized, Vehicle-Controlled Clinical Trial. Aesthet Surg J. 2021 Aug 13;41(9):1003-1010. PMID: 34128526. https://doi.org/10.1093/asj/sjab024
  7. Fu Z, Huang H, Huang J. Efficacy and safety of botulinum toxin type A for postoperative scar prevention and wound healing improvement: A systematic review and meta-analysis. J Cosmet Dermatol. 2022;21(1):176-190.  https://doi.org/10.1111/jocd.14617
  8. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17(1-2):113-125.  https://doi.org/10.2119/molmed.2009.00153
  9. Hinz B. The role of myofibroblasts in wound healing. Curr Res Transl Med. 2016;64(4):171-177.  https://doi.org/10.1016/j.retram.2016.09.003
  10. Zhou N, Li D, Luo Y, Li J, Wang Y. Effects of Botulinum Toxin Type A on Microvessels in Hypertrophic Scar Models on Rabbit Ears. Biomed Res Int. 2020;2020:2170750. https://doi.org/10.1155/2020/2170750
  11. Yang Z, Lv Y, Yang Z, Cao L, Cao D. Concentration-Dependent Inhibition of Hypertrophic Scar Formation by Botulinum Toxin Type A in a Rabbit Ear Model. Aesthetic Plast Surg. 2022;46(6):3072-3079. https://doi.org/10.1007/s00266-022-03008-0
  12. Pan L, Qin H, Li C, Yang L, Li M, Kong J, Zhang G, Zhang L. Safety and efficacy of botulinum toxin type A in preventing and treating scars in animal models: A systematic review and meta-analysis. Int Wound J. 2022;19(4):774-781.  https://doi.org/10.1111/iwj.13673
  13. Rozemond H. Laboratory animal protection: the European Convention and the Dutch Act. Vet Q. 1986;8(4):346-349.  https://doi.org/10.1080/01652176.1986.9694067
  14. Gadhia K, Walmsley AD. Facial aesthetics: is botulinum toxin treatment effective and safe? A systematic review of randomised controlled trials. Br Dent J. 2009 Sept 12;207(5):E9; discussion 216-217. PMID: 19749689. https://doi.org/10.1038/sj.bdj.2009.813
  15. Tang-Liu DD-S, Aoki KR, Dolly JO, de Paiva A, Houchen TL, Chasseaud LF, Webber C. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon. 2003 Oct;42(5):461-469. PMID: 14529727. https://doi.org/10.1016/s0041-0101(03)00196-x
  16. Çalıskan E, Gamsızkan M, Açıkgöz G, Durmuş M, Toklu S, Doğrul A, Kurt A, Tunca M. Intralesional treatments for hypertrophic scars: comparison among corticosteroid, 5-fluorouracil and botulinum toxin in rabbit ear hypertrophic scar model. Eur Rev Med Pharmacol Sci. 2016;20(8):1603-1608.
  17. Liu D-Q, Li X-J, Weng X-J. Effect of BTXA on Inhibiting Hypertrophic Scar Formation in a Rabbit Ear Model. Aesthetic Plast Surg. 2017 June; 41(3):721-728. Epub 2017 Feb 08. PMID: 28180922. https://doi.org/10.1007/s00266-017-0803-5
  18. Youjin Z, Xiaoguang Y, Xiaojing Y, Dongmei F, Yuanhui W. Inhibitory effect of botulinum toxin type A on hypertrophic scar formation in rabbit ears. Genom Appl Biol. 2019;38(10):4785‐4789.
  19. Xiao Z, Qu G. Effects of botulinum toxin type A on collagen deposition in hypertrophic scars. Molecules. 2012 Feb 21;17(2):2169-2177. PMID: 22354193; PMCID: PMC6268678. https://doi.org/10.3390/molecules17022169
  20. Zhibo X, Miaobo Z. Botulinum toxin type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar. Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS. 2008 Sept;61(9):1128-1129. Epub 2008 June 13. PMID: 18555763. https://doi.org/10.1016/j.bjps.2008.05.003
  21. Zhibo X, Miaobo Z. Potential therapeutical effects of botulinum toxin type A in keloid management. Med Hypotheses. 2008;71(4):623.  https://doi.org/10.1016/j.mehy.2008.04.018
  22. Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci. 1994 May; 107(Pt 5):1137-1157. PMID: 7929624. https://doi.org/10.1242/jcs.107.5.1137
  23. Lee B-J, Jeong J-H, Wang S-G, Lee J-C, Goh E-K, Kim H-W. Effect of botulinum toxin type a on a rat surgical wound model. Clin Exp Otorhinolaryngol. 2009 Mar;2(1):20-27. Epub 2009 Mar 26. PMID: 19434287; PMCID: PMC2671832. https://doi.org/10.3342/ceo.2009.2.1.20
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.